127 related articles for article (PubMed ID: 35976970)
1. Serum Leukocyte Cell-Derived Chemotaxin 2 (LECT2) Level Is Associated with Osteoporosis.
Wang Q; Xu F; Chen J; Xie YQ; Xu SL; He WM
Lab Med; 2023 Jan; 54(1):106-111. PubMed ID: 35976970
[TBL] [Abstract][Full Text] [Related]
2. Serum leukocyte cell-derived chemotaxin 2 level is associated with atopic dermatitis patients.
Zhao K; Xu F; Jiang X; Chen J; Zhu X; Zhou Q; Xu S
Ann Palliat Med; 2021 Oct; 10(10):11006-11012. PubMed ID: 34763463
[TBL] [Abstract][Full Text] [Related]
3. Reduced serum level of leukocyte cell-derived chemotaxin 2 is associated with the presence of diabetic retinopathy.
Okumura A; Unoki-Kubota H; Yoshida-Hata N; Yamamoto-Honda R; Yamashita S; Iwata M; Tobe K; Kajio H; Noda M; Katai N; Yamagoe S; Kaburagi Y
Clin Chim Acta; 2016 Dec; 463():145-149. PubMed ID: 27816666
[TBL] [Abstract][Full Text] [Related]
4. Elevated serum levels of leukocyte cell-derived chemotaxin 2 are associated with the prevalence of metabolic syndrome.
Zheng X; Lu J; Xiang S; Zou P; Chen H; Liu J; Zeng C; He Y
Acta Diabetol; 2024 May; 61(5):643-655. PubMed ID: 38383671
[TBL] [Abstract][Full Text] [Related]
5. Increased serum leukocyte cell-derived chemotaxin 2 (LECT2) levels in obesity and fatty liver.
Okumura A; Unoki-Kubota H; Matsushita Y; Shiga T; Moriyoshi Y; Yamagoe S; Kaburagi Y
Biosci Trends; 2013 Dec; 7(6):276-83. PubMed ID: 24390366
[TBL] [Abstract][Full Text] [Related]
6. Leukocyte cell-derived chemotaxin 2 correlates with pediatric non-alcoholic fatty liver disease.
Paine-Cabrera D; Harvey LK; Robarts DR; Pritchard MT; Thyfault J; Weinman SA; Apte U; Slowik V
Clin Transl Sci; 2023 Dec; 16(12):2719-2728. PubMed ID: 37877453
[TBL] [Abstract][Full Text] [Related]
7. Visceral fat area is a strong predictor of leukocyte cell-derived chemotaxin 2, a potential biomarker of dyslipidemia.
Tanisawa K; Taniguchi H; Sun X; Ito T; Kawakami R; Sakamoto S; Higuchi M
PLoS One; 2017; 12(3):e0173310. PubMed ID: 28278265
[TBL] [Abstract][Full Text] [Related]
8. Serum 25-hydroxyvitamin D and bone turnover markers in Palestinian postmenopausal osteoporosis and normal women.
Kharroubi A; Saba E; Smoom R; Bader K; Darwish H
Arch Osteoporos; 2017 Dec; 12(1):13. PubMed ID: 28124221
[TBL] [Abstract][Full Text] [Related]
9. Circulating LECT2 levels in newly diagnosed type 2 diabetes mellitus and their association with metabolic parameters: An observational study.
Zhang Z; Zeng H; Lin J; Hu Y; Yang R; Sun J; Chen R; Chen H
Medicine (Baltimore); 2018 Apr; 97(15):e0354. PubMed ID: 29642178
[TBL] [Abstract][Full Text] [Related]
10. Suppressive role of leukocyte cell-derived chemotaxin 2 in mouse anti-type II collagen antibody-induced arthritis.
Okumura A; Saito T; Otani I; Kojima K; Yamada Y; Ishida-Okawara A; Nakazato K; Asano M; Kanayama K; Iwakura Y; Suzuki K; Yamagoe S
Arthritis Rheum; 2008 Feb; 58(2):413-21. PubMed ID: 18240267
[TBL] [Abstract][Full Text] [Related]
11. Leukocyte cell-derived chemotaxin 2 promotes the development of nonalcoholic fatty liver disease through STAT-1 pathway in mice.
Wang J; Chen Y; Pan R; Wu C; Chen S; Li L; Li Y; Yu C; Meng ZX; Xu C
Liver Int; 2021 Apr; 41(4):777-787. PubMed ID: 33555112
[TBL] [Abstract][Full Text] [Related]
12. Role of leukocyte cell-derived chemotaxin 2 as a biomarker in hepatocellular carcinoma.
Okabe H; Delgado E; Lee JM; Yang J; Kinoshita H; Hayashi H; Tsung A; Behari J; Beppu T; Baba H; Monga SP
PLoS One; 2014; 9(6):e98817. PubMed ID: 24892551
[TBL] [Abstract][Full Text] [Related]
13. Leukocyte cell-derived chemotaxin 2 inhibits development of atherosclerosis in mice.
He WM; Dai T; Chen J; Wang JA
Zool Res; 2019 Jul; 40(4):317-323. PubMed ID: 31310065
[TBL] [Abstract][Full Text] [Related]
14. Plasma half-life and tissue distribution of leukocyte cell-derived chemotaxin 2 in mice.
Kikuchi A; Takayama H; Tsugane H; Shiba K; Chikamoto K; Yamamoto T; Matsugo S; Ishii KA; Misu H; Takamura T
Sci Rep; 2020 Aug; 10(1):13260. PubMed ID: 32764719
[TBL] [Abstract][Full Text] [Related]
15. Rapid response of the steatosis-sensing hepatokine LECT2 during diet-induced weight cycling in mice.
Chikamoto K; Misu H; Takayama H; Kikuchi A; Ishii KA; Lan F; Takata N; Tajima-Shirasaki N; Takeshita Y; Tsugane H; Kaneko S; Matsugo S; Takamura T
Biochem Biophys Res Commun; 2016 Sep; 478(3):1310-6. PubMed ID: 27562717
[TBL] [Abstract][Full Text] [Related]
16. Association of leukocyte cell-derived chemotaxin 2 (LECT2) with NAFLD, metabolic syndrome, and atherosclerosis.
Yoo HJ; Hwang SY; Choi JH; Lee HJ; Chung HS; Seo JA; Kim SG; Kim NH; Baik SH; Choi DS; Choi KM
PLoS One; 2017; 12(4):e0174717. PubMed ID: 28376109
[TBL] [Abstract][Full Text] [Related]
17. Leukocyte cell-derived chemotaxin-2 and fibroblast growth factor 21 in alcohol-induced liver cirrhosis.
Sak JJ; Prystupa A; Kiciński P; Luchowska-Kocot D; Kurys-Denis E; Bis-Wencel H
World J Hepatol; 2021 Dec; 13(12):2071-2080. PubMed ID: 35070009
[TBL] [Abstract][Full Text] [Related]
18. Leukocyte Cell-Derived Chemotaxin 2 Retards Non-Small Cell Lung Cancer Progression Through Antagonizing MET and EGFR Activities.
Hung WY; Chang JH; Cheng Y; Chen CK; Chen JQ; Hua KT; Cheng CW; Hsiao M; Chung CL; Lee WJ; Chien MH
Cell Physiol Biochem; 2018; 51(1):337-355. PubMed ID: 30453282
[TBL] [Abstract][Full Text] [Related]
19. TGF-β1-Mediated Leukocyte Cell-Derived Chemotaxin 2 Is Associated With Liver Fibrosis in Biliary Atresia.
Zhao J; Xu X; Gou Q; Zheng Q; Ge L; Chen L; Zhang C; Ma H; Lin S; Hu X; Zhan J
Front Pediatr; 2022; 10():901888. PubMed ID: 35928681
[TBL] [Abstract][Full Text] [Related]
20. Global research trends and hotspots for leukocyte cell-derived chemotaxin-2 from the past to 2023: a combined bibliometric review.
Liu W; Wang Q; Yeerlan J; Yan Y; Xu L; Jia C; Liu X; Zhang L
Front Immunol; 2024; 15():1413466. PubMed ID: 38881894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
